3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Solid Tumor
1
Interventions
tazemetostat
1
pazopanib
1
omburtamab I-131
1
molibresib
1
marizomib
1
carotuximab
1
Capecitabine
1
Bevacizumab
1
Axitinib
1
Afatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
marizomib
×
Other solid neoplasm
×
Clear all
NCT04644107
2020-11-25
Expanded Access for Marizomib
Celgene
No longer available